BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 14648068)

  • 1. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
    Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
    Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death.
    Kim HR; Kim K; Lee KH; Kim SJ; Kim J
    Clin Exp Immunol; 2008 May; 152(2):336-44. PubMed ID: 18336591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
    Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cell membrane potential and natural killer cell cytolysis in human hepatocellular carcinoma cells.
    Stevenson D; Binggeli R; Weinstein RC; Keck JG; Lai MC; Tong MJ
    Cancer Res; 1989 Sep; 49(17):4842-5. PubMed ID: 2547520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor.
    Richards AL; Dennert G; Pluznik DH; Takagaki Y; Djeu JY
    Nat Immun Cell Growth Regul; 1989; 8(2):76-88. PubMed ID: 2761550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
    Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
    Brenner BG; McCrea EL; Margolese RG
    Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells.
    Zamai L; Ahmad M; Bennett IM; Azzoni L; Alnemri ES; Perussia B
    J Exp Med; 1998 Dec; 188(12):2375-80. PubMed ID: 9858524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
    Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
    Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
    Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells.
    Sarzotti M; Klimpel GR; Baron S
    Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor-initiated proliferation of mouse embryonic fibroblasts induces cytotoxicity by natural killer cells and by a non-cytolysin cytotoxin in natural killer granules.
    Khalil N; Battistuzzi SC; Kraut RP; Schwarz LC; Greenberg AH
    J Immunol; 1990 Aug; 145(4):1286-92. PubMed ID: 2380558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
    Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1.
    Herman J; Dinarello CA; Kew MC; Rabson AR
    J Immunol; 1985 Oct; 135(4):2882-6. PubMed ID: 2993420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
    Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
    J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.